Deerfield Management Company »

Avalyn Pharma shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Avalyn Pharma shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Avalyn Pharma

Tip: Access up to 7 years of quarterly data

All positions including Avalyn Pharma held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalyn Pharma by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $24M 731k 32.92

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Brookdale Sr Living Note 3.500%10/1 (Principal)
Revolution Medicines (RVMD)
Praxis Precision Medicines I Com New (PRAX)
Viatris (VTRS)
Centene Corporation (CNC)
Revolution Medicines Note 0.500% 5/0 (Principal)
United Therapeutics Corporation (UTHR)
Arrowhead Pharmaceuticals In Note 1/1 (Principal)
Legend Biotech Corp Sponsored Ads (LEGN)
Cogent Biosciences (COGT)
Genmab A/s Sponsored Ads (GMAB)
Brookdale Senior Living (BKD)
Vera Therapeutics Cl A (VERA)
Ionis Pharmaceuticals (IONS)

View all positions for Deerfield Management Company

Top funds holding Avalyn Pharma

FMR
Novo A/S
Sr One Capital Management
Perceptive Advisors
NVP Associates
Wellington Management Company
Pivotal bioVenture Partners Investment Advisor
Citadel Advisors
Jennison Associates
Braidwell
Vanguard Capital Management
Deerfield Management Company
Geode Capital Management
Soleus Capital Management
Infinitum Asset Management

View all funds holding Avalyn Pharma